EC Number   |
Disease |
PubMed ID |
Title of Publication |
Category |
Confidence Level |
|---|
   1.6.5.9 | Infections |
29524843 |
Regulation of the mechanism of Type-II NADH: Quinone oxidoreductase from S. aureus. |
causal interaction
diagnostic usage
unassigned |
1
3
0 |
| 1.6.5.9 | Leishmaniasis |
23946481 |
An Essential Type I Nitroreductase from Leishmania major Can Be Used to Activate Leishmanicidal Prodrugs. |
therapeutic application
unassigned |
4
0 |
| 1.6.5.9 | Mitochondrial Diseases |
18603533 |
Iron-sulfur cluster N5 is coordinated by an HXXXCXXCXXXXXC motif in the NuoG subunit of Escherichia coli NADH:quinone oxidoreductase (complex I). |
causal interaction
unassigned |
4
0 |
| 1.6.5.9 | Mitochondrial Diseases |
29421444 |
Alternative NAD(P)H dehydrogenase and alternative oxidase: Proposed physiological roles in animals. |
causal interaction
unassigned |
1
0 |
| 1.6.5.9 | nadh:ubiquinone reductase (h+-translocating) deficiency |
20398675 |
Molecular Gene Therapy: Overexpression of the Alternative NADH Dehydrogenase NDI1 Restores Overall Physiology in a Fungal Model of Respiratory Complex I Deficiency. |
causal interaction
ongoing research
unassigned |
3
2
0 |
| 1.6.5.9 | Parkinson Disease |
19904590 |
Parkinson's disease and mitochondrial complex I: a perspective on the Ndi1 therapy. |
ongoing research
therapeutic application
unassigned |
1
4
0 |
